 SAN DIEGO, Sept. 25, 2021 PRNewswire -- Robbins Geller Rudman Dowd LLP announces that purchasers or acquirers of Iterum Therapeutics plc NASDAQ: ITRM securities between November 30, 2020 and July 23, 2021, inclusive Class Period have until October 4, 2021 to seek appointment as lead plaintiff. 